You are here

Xpovio

Karyopharm cuts staff amid push to broaden use of blood cancer drug

BioPharma Dive

Wed, 08/2/23 - 10:38 pm

Karyopharm Therapeutics

CTOS 2020 – Karyopharm seeks a solid tumour Seal of approval

EP Vantage

Mon, 11/2/20 - 11:01 pm

Karyopharm’s Xpovio Wins Second FDA Approval for DLBCL Treatment

BioSpace

Tue, 06/23/20 - 10:53 am

Karyopharm posts positive data from Phase III trial of multiple myeloma drug

MedCity News

Thu, 03/5/20 - 10:56 am

Multiple Myeloma

clinical trials

Karyopharm spotlights PhIII results after controversial FDA approval

Endpoints

Mon, 03/2/20 - 11:01 am

Karyopharm Therapeutics

clinical trials

Upcoming events – Karyopharm's myeloma expansion and Pfizer's biz dev news

EP Vantage

Sun, 01/5/20 - 07:11 pm

Multiple Myeloma

Ionis Pharmaceuticals

AKCEA-ANGPTL3-Lrx

Karyopharm drug tested in ‘industry-first’ approach to brain cancer

Pharmaforum

Fri, 07/12/19 - 12:05 pm

clinical trials

Karyopharm’s Xpovio nabs myeloma nod despite checkered past. But 5th line?

Fierce Pharma

Mon, 07/8/19 - 08:07 pm

Multiple Myeloma

After negative panel vote, FDA approves Karyopharm's multiple myeloma drug

BioCentury

Fri, 07/5/19 - 01:36 pm

Multiple Myeloma